Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.700 HKD | +0.82% |
|
+2.21% | -0.80% |
Mar. 05 | Lee & Man Chemical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024 | CI |
2024 | Lee & Man Chemical Company Limited(SEHK:746) dropped from S&P Global BMI Index | CI |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 3.1B | 5.19B | 5.87B | 4.05B | 3.95B | |||||
Total Revenues | 3.1B | 5.19B | 5.87B | 4.05B | 3.95B | |||||
Cost of Goods Sold, Total | 1.97B | 2.85B | 3.74B | 2.99B | 2.79B | |||||
Gross Profit | 1.13B | 2.34B | 2.12B | 1.06B | 1.16B | |||||
Selling General & Admin Expenses, Total | 425M | 532M | 531M | 468M | 478M | |||||
R&D Expenses | 154M | 231M | 204M | 121M | 136M | |||||
Other Operating Expenses, Total | 578M | 763M | 735M | 589M | 614M | |||||
Operating Income | 553M | 1.58B | 1.39B | 473M | 551M | |||||
Interest Expense, Total | -55.85M | -47.62M | -38.66M | -39.28M | -21.9M | |||||
Interest And Investment Income | 5.98M | 4.79M | 5.9M | 4.54M | 4.58M | |||||
Net Interest Expenses | -49.87M | -42.83M | -32.76M | -34.75M | -17.31M | |||||
Income (Loss) On Equity Invest. | -8.69M | -1.24M | 312K | 543K | 3.69M | |||||
Currency Exchange Gains (Loss) | 42.22M | 23.25M | -21.01M | -6.98M | 2.35M | |||||
Other Non Operating Income (Expenses) | 91M | 61.15M | 60.95M | 75.41M | 58.31M | |||||
EBT, Excl. Unusual Items | 628M | 1.62B | 1.4B | 508M | 598M | |||||
Gain (Loss) On Sale Of Investments | 1.03M | -3.09M | 5.17M | -2.11M | 1.09M | |||||
Gain (Loss) On Sale Of Assets | -789K | -1.7M | -2.79M | -2.67M | -2.44M | |||||
Asset Writedown | - | - | - | -8.84M | - | |||||
Other Unusual Items | - | - | - | - | - | |||||
EBT, Incl. Unusual Items | 628M | 1.61B | 1.4B | 494M | 596M | |||||
Income Tax Expense | 125M | 323M | 241M | 93.23M | 114M | |||||
Earnings From Continuing Operations | 503M | 1.29B | 1.16B | 401M | 482M | |||||
Net Income to Company | 503M | 1.29B | 1.16B | 401M | 482M | |||||
Minority Interest | - | - | - | - | - | |||||
Net Income - (IS) | 503M | 1.29B | 1.16B | 401M | 482M | |||||
Net Income to Common Incl Extra Items | 503M | 1.29B | 1.16B | 401M | 482M | |||||
Net Income to Common Excl. Extra Items | 503M | 1.29B | 1.16B | 401M | 482M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.61 | 1.56 | 1.4 | 0.49 | 0.58 | |||||
Basic EPS - Continuing Operations | 0.61 | 1.56 | 1.4 | 0.49 | 0.58 | |||||
Basic Weighted Average Shares Outstanding | 825M | 825M | 825M | 825M | 825M | |||||
Net EPS - Diluted | 0.61 | 1.51 | 1.34 | 0.48 | 0.58 | |||||
Diluted EPS - Continuing Operations | 0.61 | 1.51 | 1.34 | 0.48 | 0.58 | |||||
Diluted Weighted Average Shares Outstanding | 825M | 854M | 861M | 838M | 825M | |||||
Normalized Basic EPS | 0.48 | 1.22 | 1.06 | 0.38 | 0.45 | |||||
Normalized Diluted EPS | 0.48 | 1.18 | 1.01 | 0.38 | 0.45 | |||||
Dividend Per Share | 0.24 | 0.58 | 0.55 | 0.19 | 0.29 | |||||
Payout Ratio | 36.93 | 27.22 | 49.92 | 45.3 | 47.89 | |||||
Supplemental Items | ||||||||||
EBITDA | 600M | 1.63B | 1.46B | 532M | 624M | |||||
EBITA | 556M | 1.58B | 1.39B | 476M | 553M | |||||
EBIT | 553M | 1.58B | 1.39B | 473M | 551M | |||||
EBITDAR | - | 1.63B | 1.46B | 532M | 624M | |||||
Total Revenues (As Reported) | - | - | 5.87B | 4.05B | 3.95B | |||||
Effective Tax Rate - (Ratio) | 19.98 | 20.05 | 17.26 | 18.88 | 19.11 | |||||
Current Domestic Taxes | 124M | 322M | 267M | 126M | 124M | |||||
Total Current Taxes | 124M | 322M | 267M | 126M | 124M | |||||
Deferred Domestic Taxes | 9.46M | 14.86M | -4.04M | -29.63M | 2.92M | |||||
Total Deferred Taxes | 9.46M | 14.86M | -4.04M | -29.63M | 2.92M | |||||
Normalized Net Income | 392M | 1.01B | 872M | 317M | 373M | |||||
Interest Capitalized | 2.59M | 1.96M | - | - | - | |||||
Interest on Long-Term Debt | 71K | 235K | 159K | 58K | 180K | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 201M | 233M | 254M | 209M | 203M | |||||
General and Administrative Expenses | 223M | 299M | 277M | 259M | 275M | |||||
Research And Development Expense From Footnotes | 157M | 234M | 207M | 123M | 138M | |||||
Net Rental Expense, Total | - | 315K | 205K | 144K | 126K | |||||
Imputed Operating Lease Interest Expense | - | 97K | 71.08K | 63.5K | 33.14K | |||||
Imputed Operating Lease Depreciation | - | 218K | 134K | 80.5K | 92.86K | |||||
Stock-Based Comp., Other (Total) | 32.78M | 32.68M | 8.06M | - | - | |||||
Total Stock-Based Compensation | 32.78M | 32.68M | 8.06M | - | - |
Select your edition
All financial news and data tailored to specific country editions